UBS Group’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.4M | Buy |
301,926
+125,826
| +71% | +$2.98M | ﹤0.01% | 3652 |
|
|
2025
Q4 | $4.37M | Buy |
176,100
+57,432
| +48% | +$1.53M | ﹤0.01% | 4168 |
|
|
2025
Q3 | $3.36M | Buy |
118,668
+25,996
| +28% | +$704K | ﹤0.01% | 4446 |
|
|
2025
Q2 | $2.31M | Buy |
92,672
+59
| +0.1% | +$1.66K | ﹤0.01% | 4663 |
|
|
2025
Q1 | $2.87M | Buy |
92,613
+11,522
| +14% | +$384K | ﹤0.01% | 4358 |
|
|
2024
Q4 | $2.56M | Buy |
81,091
+66,539
| +457% | +$3.16M | ﹤0.01% | 4489 |
|
|
2024
Q3 | $843K | Buy |
14,552
+4,465
| +44% | +$219K | ﹤0.01% | 4801 |
|
|
2024
Q2 | $409K | Sell |
10,087
-25,268
| -71% | -$1M | ﹤0.01% | 5163 |
|
|
2024
Q1 | $1.48M | Sell |
35,355
-3,985
| -10% | -$155K | ﹤0.01% | 4238 |
|
|
2023
Q4 | $1.51M | Buy |
39,340
+28,729
| +271% | +$957K | ﹤0.01% | 4110 |
|
|
2023
Q3 | $327K | Sell |
10,611
-42,001
| -80% | -$1.45M | ﹤0.01% | 4981 |
|
|
2023
Q2 | $1.66M | Buy |
52,612
+37,145
| +240% | +$1.27M | ﹤0.01% | 3706 |
|
|
2023
Q1 | $564K | Buy |
15,467
+5,690
| +58% | +$199K | ﹤0.01% | 4594 |
|
|
2022
Q4 | $289K | Buy |
9,777
+8,442
| +632% | +$271K | ﹤0.01% | 5163 |
|
|
2022
Q3 | $52K | Buy |
+1,335
| New | +$61.1K | ﹤0.01% | 6323 |
|
|
2022
Q1 | – | Sell |
-10,916
| Closed | -$802K | – | 11008 |
|
|
2021
Q4 | $802K | Buy |
10,916
+9,007
| +472% | +$740K | ﹤0.01% | 4578 |
|
|
2021
Q3 | $174K | Sell |
1,909
-3,554
| -65% | -$302K | ﹤0.01% | 5426 |
|
|
2021
Q2 | $343K | Buy |
5,463
+4,044
| +285% | +$150K | ﹤0.01% | 4994 |
|
|
2021
Q1 | $38K | Sell |
1,419
-4,466
| -76% | -$107K | ﹤0.01% | 6807 |
|
|
2020
Q4 | $108K | Buy |
5,885
+4,111
| +232% | +$73.9K | ﹤0.01% | 5639 |
|
|
2020
Q3 | $32K | Sell |
1,774
-891
| -33% | -$15.4K | ﹤0.01% | 5954 |
|
|
2020
Q2 | $44K | Sell |
2,665
-1,249
| -32% | -$19.7K | ﹤0.01% | 5966 |
|
|
2020
Q1 | $51K | Sell |
3,914
-2,682
| -41% | -$43.8K | ﹤0.01% | 5817 |
|
|
2019
Q4 | $121K | Sell |
6,596
-7,368
| -53% | -$122K | ﹤0.01% | 5908 |
|
|
2019
Q3 | $246K | Buy |
13,964
+12,637
| +952% | +$216K | ﹤0.01% | 5082 |
|
|
2019
Q2 | $22K | Buy |
1,327
+1,227
| +1,227% | +$22.3K | ﹤0.01% | 6556 |
|
|
2019
Q1 | $2K | Sell |
100
-2,231
| -96% | -$42.8K | ﹤0.01% | 7476 |
|
|
2018
Q4 | $46K | Sell |
2,331
-2,237
| -49% | -$41.9K | ﹤0.01% | 6171 |
|
|
2018
Q3 | $101K | Buy |
4,568
+272
| +6% | +$5.73K | ﹤0.01% | 5595 |
|
|
2018
Q2 | $111K | Buy |
4,296
+4,196
| +4,196% | +$71.9K | ﹤0.01% | 5374 |
|
|
2018
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 7563 |
|
|
2017
Q4 | $2K | Buy |
+100
| New | +$2.01K | ﹤0.01% | 7635 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
